Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine

The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceno, Janaína Jamile Ferreira, Souza, Guilherme Macedo, dos Santos Finamor, Luciana Peixoto, Nascimento, Heloisa Moraes, Belfort, Rubens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404022/
https://www.ncbi.nlm.nih.gov/pubmed/34462013
http://dx.doi.org/10.1186/s40942-021-00319-3
_version_ 1783746083550134272
author Saraceno, Janaína Jamile Ferreira
Souza, Guilherme Macedo
dos Santos Finamor, Luciana Peixoto
Nascimento, Heloisa Moraes
Belfort, Rubens
author_facet Saraceno, Janaína Jamile Ferreira
Souza, Guilherme Macedo
dos Santos Finamor, Luciana Peixoto
Nascimento, Heloisa Moraes
Belfort, Rubens
author_sort Saraceno, Janaína Jamile Ferreira
collection PubMed
description The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.
format Online
Article
Text
id pubmed-8404022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84040222021-08-30 Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine Saraceno, Janaína Jamile Ferreira Souza, Guilherme Macedo dos Santos Finamor, Luciana Peixoto Nascimento, Heloisa Moraes Belfort, Rubens Int J Retina Vitreous Letter to the Editor The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist. BioMed Central 2021-08-30 /pmc/articles/PMC8404022/ /pubmed/34462013 http://dx.doi.org/10.1186/s40942-021-00319-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Saraceno, Janaína Jamile Ferreira
Souza, Guilherme Macedo
dos Santos Finamor, Luciana Peixoto
Nascimento, Heloisa Moraes
Belfort, Rubens
Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title_full Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title_fullStr Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title_full_unstemmed Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title_short Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
title_sort vogt-koyanagi-harada syndrome following covid-19 and chadox1 ncov-19 (azd1222) vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404022/
https://www.ncbi.nlm.nih.gov/pubmed/34462013
http://dx.doi.org/10.1186/s40942-021-00319-3
work_keys_str_mv AT saracenojanainajamileferreira vogtkoyanagiharadasyndromefollowingcovid19andchadox1ncov19azd1222vaccine
AT souzaguilhermemacedo vogtkoyanagiharadasyndromefollowingcovid19andchadox1ncov19azd1222vaccine
AT dossantosfinamorlucianapeixoto vogtkoyanagiharadasyndromefollowingcovid19andchadox1ncov19azd1222vaccine
AT nascimentoheloisamoraes vogtkoyanagiharadasyndromefollowingcovid19andchadox1ncov19azd1222vaccine
AT belfortrubens vogtkoyanagiharadasyndromefollowingcovid19andchadox1ncov19azd1222vaccine

Ejemplares similares